RAM
MIRM icon

RWC Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

RWC Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,341
Closed -$216K – 173
2026
Q1 		$216K Sell
2,341
-793
-25% -$74.6K 0.01% 159
2025
Q4 		$248K Sell
3,134
-663
-17% -$47.6K 0.01% 158
2025
Q3 		$278K Buy
+3,797
New +$241K 0.01% 162

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RWC Asset Management's MIRM Position: Q2 2026 in Review

RWC Asset Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 2,341 shares — an estimated $216K sold.

RWC Asset Management first reported a position in MIRM in Q3 2025 and held it in 3 quarters. The position peaked at $278K in Q3 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • RWC Asset Management reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • RWC Asset Management sold 2,341 Mirum Pharmaceuticals shares in Q2 2026, an estimated $216K.
  • RWC Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • RWC Asset Management's Mirum Pharmaceuticals position peaked at $278K in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on RWC Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.